1. Werner Kühlbrandt  Is a corresponding author
  1. Max Planck Institute of Biophysics, Germany

The development of new detector hardware has led to a resolution revolution in electron cryo-microscopy (cryo-EM; Kühlbrandt, 2014). This is evident from a series of striking new structures obtained by cryo-EM at near-atomic resolution: these include ribosomes from human pathogens (Wong et al., 2014) or mitochondria (Amunts et al., 2014), ribosomes in complex with a protein translocase (Voorhees et al., 2014), ion channels (Liao et al., 2013; Cao et al., 2013), or a key enzyme in the biogenesis of methane (Allegretti et al., 2014). The ability to solve such structures in atomic detail is an essential prerequisite for the development of novel antibiotics and drugs.

The complexes mentioned above are mostly in the megadalton size range, which has long been the domain of cryo-EM. Recently, however, a team of researchers led by Sjors Scheres of the MRC Laboratory of Molecular Biology (LMB) and Yigong Shi of Tsinghua University showed that cryo-EM can also be used for smaller, asymmetrical membrane proteins (Lu et al., 2014). They did this by working out the structure of an enzyme called the human γ-secretase complex at a resolution of 4.5 Å: this enzyme cleaves a variety of proteins within cells, and if it does not work properly, the end result can be Alzheimer's disease. The ordered regions of this complex have a molecular mass of 170 kilodaltons (kDa), which was previously thought to be too small for cryo-EM, even when the latest direct electron detectors were being used. Now, in eLife, Scheres describes the methods that have made this breakthrough possible (Scheres, 2014).

A major advantage of cryo-EM over X-ray crystallography is that the molecule of interest does not have to be crystallized. Instead, a thin film (ideally not much thicker than the molecule itself) of an aqueous solution is rapidly frozen on a support grid—so rapidly that the water has no time to crystallize. The vitrified sample is then placed in the high vacuum of the electron microscope, where it is cooled with liquid nitrogen to −180°C. Projection images of multiple copies of the molecule, suspended in random orientations in the vitrified film, are recorded with a beam of 200 kV or 300 kV electrons, and the structure of the molecule is determined by combining the projection images into a 3D molecular volume in a computer.

Because the information in each image is noisy and incomplete, tens or hundreds of thousands of particle images are aligned and averaged. The quality of the final map of the molecule depends on the accuracy to which the particle images can be aligned. This works better for larger particles that are more easily visible, and therefore there is a lower size limit in cryo-EM, which until now was thought to be around 300 kDa. However, it should be noted that, with perfect images, theoretical considerations (Henderson, 1995) indicate a lower size limit of 38 kDa.

The main challenge in cryo-EM is low signal-to-noise ratio or, in other words, poor image contrast. Low contrast is the inevitable consequence of the fact that all biological objects and their components—proteins, nucleic acids, carbohydrates, lipids—are radiation-sensitive. In order to determine their structures in atomic detail, as is necessary to understand how they function in the cell, only very low electron doses can be applied. Exposures above a critical limit break covalent bonds irreversibly, destroying the very detail we want to know about.

To make matters worse, the particles must not move by more than about 1 Å, which is equivalent to the diameter of one hydrogen atom, while an image is being recorded. However, much larger movements usually occur when the electron beam hits a biological specimen, possibly due to the release of stresses that result from the sample and the gird and film that support it all having different thermal expansion coefficients. Electron irradiation breaks covalent bonds and creates gas molecules (such as hydrogen, oxygen, nitrogen and methane) that push through the ice to escape. These unavoidable beam-induced movements have made it extremely difficult to collect high-resolution electron micrographs of biological macromolecules in the past.

It takes seconds to record a low-dose image on conventional media (CCD cameras or photographic film), during which time small movements build up and blur the high-resolution features. The new direct electron detectors are both more sensitive and much faster than conventional media. Instead of a single, second-long exposure, they record movies at a rate of many frames per second. Successive movie frames are compared in order to detect any movements on the Å scale. Once the movements of the particles have been traced, they can be reversed in the computer. The movie frames are then added up to give one much sharper, motion-corrected image.

To take full advantage of the new detector hardware, programs were developed to perform movie processing and motion correction (Bai et al., 2013; Li et al., 2013) and, above all, to extract the precious structural information from noisy images in an optimal way. A program suite based on maximum likelihood and prior knowledge (such as a reference volume) about the structure to be determined (Scheres, 2012) has taken the field by storm. The new software works largely without user intervention and provides objective resolution criteria that have quickly become the ‘gold standard’ in cryo-EM. Standardized validation procedures make results more reliable (Rosenthal and Henderson, 2003) and produce clearer maps by helping to avoid over-fitted noise (Scheres and Chen, 2012) that has bedeviled many of the previously published single-particle cryo-EM structures. Powerful classification schemes separate different molecules (Amunts et al., 2014) or distinct structural states of the same molecule (Fernandez et al., 2013) that may be simultaneously present in one field of view. In effect, the sample is purified in the computer rather than by arduous, time-consuming and often damaging biochemical procedures.

For large assemblies, such as ribosomes, movements are corrected for each particle individually, but this is not feasible for small, low-contrast proteins. Instead, Scheres has now extended his original procedure to include statistical movie processing of an ensemble of particles and to take beam-induced motion and radiation damage into account. This has resulted in the structure of the γ-secretase complex at 4.5 Å resolution (from 144,000 particles), and also in significant improvements of several other structures. The 4.5 Å map reveals the secondary structure of the complex, both in the cytoplasmic domain and in the membrane, where the active site resides (Lu et al., 2014; Figure 1).

Cryo-EM structure of the human γ-secretase complex.

(A) Electron micrograph showing how the γ-secretase particles are moved by the electron beam (blue tracks; movement multiplied by a factor of 50 to make it visible). Scheres and co-workers have developed techniques (Bai et al., 2013; Scheres, 2014) to correct for these movements, and used them to determine the structure of the human γ-secretase complex at a resolution of 4.5 Å (Lu et al., 2014). This approach involves fitting linear tracks to the real movements: the fitted tracks are shown in white, with their start and end points being shown in green and red, respectively; the orange circle outlines the ensemble of particles used for statistical processing to fit the track of one particle (Scheres, 2014). (B) 3D map of the γ-secretase complex. The 19 trans-membrane helices of the four subunits that contain the active site of the complex are shown in blue, and the extracellular domain is shown in green. The inset shows an alpha helix with partly resolved sidechains in the extracellular domain.

CREDIT Scheres.

While this result is unprecedented and exciting, the structure-based development of inhibitors that might delay the onset of Alzheimer's disease will require the amino acid sidechains in the active site of the complex to be resolved at 3 Å or better. For the time being, this remains unattainable for such small protein assemblies, even with the latest detector technology and software, but further improvements are on the horizon. These include thinner detector chips and faster readout rates, which will greatly enhance the signal-to-noise ratio at high resolution, improvements in specimen preparation, the use of supports that are less prone to move under electron bombardment, and new image recording procedures that reduce beam-induced movement.

Once all these developments are in place, the 20-year old dream of being able to use cryo-EM to determine atomic-resolution structures from just a few thousand particles (Henderson, 1995) may finally come true. Until then, the combination of direct electron detectors and reliable image processing programs is keeping the field moving forward at a rapid rate.


Article and author information

Author details

  1. Werner Kühlbrandt

    Department of Structural Biology, Max Planck Institute of Biophysics, Frankfurt, Germany
    For correspondence
    Competing interests
    The author declares that no competing interests exist.

Publication history

  1. Version of Record published: August 13, 2014 (version 1)


© 2014, Kühlbrandt

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.


  • 13,190
    Page views
  • 1,542
  • 179

Article citation count generated by polling the highest count across the following sources: Crossref, Scopus, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Werner Kühlbrandt
Microscopy: Cryo-EM enters a new era
eLife 3:e03678.

Further reading

    1. Structural Biology and Molecular Biophysics
    Josip Ivica et al.
    Research Article

    To clarify the determinants of agonist efficacy in pentameric ligand-gated ion channels we examined a new compound, aminomethanesulfonic acid (AMS), a molecule intermediate in structure between glycine and taurine. Despite wide availability, to date there are no reports of AMS action on glycine receptors, perhaps because AMS is unstable at physiological pH. Here we show that at pH 5, AMS is an efficacious agonist, eliciting in zebrafish α1 glycine receptors a maximum single channel open probability of 0.85, much greater than that of β-alanine (0.54) or taurine (0.12), and second only to that of glycine itself (0.96). Thermodynamic cycle analysis of the efficacy of these closely related agonists shows supra-additive interaction between changes in the length of the agonist molecule and the size of the anionic moiety. Single particle cryo-EM structures of AMS-bound glycine receptors show that the AMS-bound agonist pocket is as compact as with glycine, and three-dimensional classification demonstrates that the channel populates the open and the desensitized states, like glycine, but not the closed intermediate state associated with the weaker partial agonists, β-alanine and taurine. Because AMS is on the cusp between full and partial agonists, it provides a new tool to help us understand agonist action in the pentameric superfamily of ligand-gated ion channels.

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Scott D Hansen et al.
    Research Article

    The phosphatidylinositol 4-phosphate 5-kinase (PIP5K) family of lipid modifying enzymes generate the majority of phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) lipids found at the plasma membrane in eukaryotic cells. PI(4,5)P2 lipids serve a critical role in regulating receptor activation, ion channel gating, endocytosis, and actin nucleation. Here we describe how PIP5K activity is regulated by cooperative binding to PI(4,5)P2 lipids and membrane-mediated dimerization of the kinase domain. In contrast to constitutively dimeric phosphatidylinositol 5-phosphate 4-kinase (PIP4K, type II PIPK), solution PIP5K exists in a weak monomer-dimer equilibrium. PIP5K monomers can associate with PI(4,5)P2 containing membranes and dimerize in a protein density dependent manner. Although dispensable for cooperative PI(4,5)P2 binding, dimerization enhances the catalytic efficiency of PIP5K through a mechanism consistent with allosteric regulation. Additionally, dimerization amplifies stochastic variation in the kinase reaction velocity and strengthens effects such as the recently described stochastic geometry sensing. Overall, the mechanism of PIP5K membrane binding creates a broad dynamic range of lipid kinase activities that are coupled to the density of PI(4,5)P2 and membrane bound kinase.